2 Nov
2000
2 Nov
'00
9:52 a.m.
On Wed, 1 Nov 2000, Greg Broiles wrote:
I'm aware of one example of a similar use in a NASDAQ-listed FDA-regulated pharmaceutical company, where they have a staff of "document czars" who are the only ones empowered to produce, edit, and maintain archives of documents considered especially critical to their intellectual property and/or research and production records required to gain and keep FDA listing for their products. I get the impression that's standard practice in the industry; and probably standard practice anywhere, where the continued availability (or confidentiality) of documents can turn into gains or losses in the $100M - $10B range.
Document translation, especialy patent and trademark,
Also draft contracts and agreements...